Chiron Sneezes, Investors Catch Cold
96760
British authorities shut down the pharmaceutical's only U.S. flu vaccine manufacturing facility.
393985
The Food and Drug Administration is unlikely to clear influenza vaccine made by Chiron Corp. as safe for Americans to use this flu season, Dr.
241357
Investor's Business Daily - He focuses his research for the Janus Enterprise Fund  (NASDAQ:JAENX - News) on mid-cap companies with steadily rising revenue, earnings and return on capital. His portfolio spans consumer goods and services, health care, biotech, information technology, financial services and energy companies.
475931
Individual investors are struggling to find a balanced approach at an unreliable time for the market.
264090
NEW YORK - As Wall Street sifts through more than 300 third-quarter earnings reports this week, technology and pharmaceutical stocks will be getting some of the closest scrutiny.    The focus on drug companies results from a recent spate of bad news about Merck & Co...
211672
Shares of Allergan Inc. dipped 4.3 percent Tuesday after four individuals were admitted to hospitals with symptoms believed to be indicative of botulism, some of whom may have received injections of Allergan
609330
The world is unprepared for an inevitable flu pandemic that could kill tens of millions of people, but profit-driven pharmaceutical companies are putting too little
70548
Chiron Corp.&#39;s aggressive plan to dominate the US flu-vaccine market is in tatters and the company&#39;s financial future is clouded as the public health crisis it caused continues to mount.
395000
Chiron Corporation last Friday provided the following statement in response to an announcement by U.S. health officials on the current influenza vaccine situation.
356640
A grand jury subpeona for records about its flu vaccine points to possible criminal violations. Next: A flood of civil suits. Over the last year-and-a-half, Chiron (CHIR ) had been making strides in reinventing itself.
610181
Stock market investors are infamous for their laser focus on immediate results when they put a price on risk and potential reward every day. Unless, of course, they're investing in biotech stocks.
753455
Pfizer to investors: Don't stop believing.
479150
As flu season neared in late September, the drugmaker at the center of the vaccine shortage radiated confidence. Only four weeks earlier, Chiron had surprised public
19709
Last week, the Chiron Corporation, which manufactures close to half of America&#39;s influenza vaccine supply announced a delay in shipping its Fluvirin influenza virus vaccine, due to the possibility of contaminated doses.
278626
The company reports mediocre earnings as investors remain nervous about the drug sector.
99249
Standard &amp; Poor&#39;s on Tuesday said it may cut Chrion Corp.&#39;s (CHIR.O: Quote, Profile, Research) debt ratings, after the company said it will not sell flu vaccine for the coming flu season due to problems at its plant in British.
503373
This season's flu-shot shortage is enticing companies to enter a market that others have largely abandoned because of poor profits.